$0.181
-0.136 (-74.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BTAI Prediction & Forecast by Similar Chart Analysis
Alphio's BTAI stock price prediction model matches the current BioXcel Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.18 (+1.20%). The 1-week path is $0.18 (-1.07%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy BioXcel Therapeutics Inc Stock?
Given the current price of $0.1814 and the recent bankruptcy filing, BioXcel Therapeutics is not a good buy right now. The stock has plummeted 77.43% in the last five days and has a very low RSI of 10.284, indicating extreme oversold conditions. The company's financial health is concerning, with a net income loss of $14.7 million in Q2 2026 and a gross margin of only 87.91%. The main risk is the ongoing bankruptcy proceedings, which could further dilute shareholder value.
BTAI stock price ended at $0.18 on Friday, after losing -74.76%
BioXcel Therapeutics Inc (BTAI) last closed at $0.1814, losing -74.76%. These facts feed the 1-day and 1-week BTAI price prediction above.
Analyst Consensus
BioXcel Therapeutics Inc (BTAI): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
BioXcel Therapeutics Inc (BTAI) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BTAI, ranked by similarity.
Seasonality analysis for BTAI
Historically the probability of a positive August return for BTAI is 3.17%. January offers the highest probability of a positive month at 39.34%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BTAI
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.71 | $0.84 | $0.90 | +360.43% |
| Sep 2026 | $0.66 | $0.77 | $0.85 | +323.90% |
| Oct 2026 | $0.57 | $0.72 | $0.74 | +295.21% |
| Nov 2026 | $0.92 | $0.94 | $0.95 | +416.13% |
| Dec 2026 | $0.70 | $0.86 | $0.94 | +374.32% |
In 2026, BioXcel Therapeutics Inc (BTAI) is projected to range from $0.57 to $0.95.
BioXcel Therapeutics Inc 2026 monthly forecast
In Aug 2026, BioXcel Therapeutics Inc is projected to average $0.84, with a low of $0.71 and high of $0.90.
In Sep 2026, BioXcel Therapeutics Inc is projected to average $0.77, with a low of $0.66 and high of $0.85.
In Oct 2026, BioXcel Therapeutics Inc is projected to average $0.72, with a low of $0.57 and high of $0.74.
In Nov 2026, BioXcel Therapeutics Inc is projected to average $0.94, with a low of $0.92 and high of $0.95.
In Dec 2026, BioXcel Therapeutics Inc is projected to average $0.86, with a low of $0.70 and high of $0.94.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.